Close Menu

NEW YORK (360Dx) – Novacyt today reported a 35 percent increase in its full-year 2017 revenues amid higher sales of its Primerdesign PCR and Novaprep liquid cytology products.

Novacyt reported 2017 revenues of €15.0 million ($18.6 million), up from €11.1 million in 2016. At constant exchange rates (CER), the company's sales were up 43 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.